4

OWNERSHIP DOCUMENT

Company: Milestone Pharmaceuticals Inc.
Filed: July 30, 2020
Period of Report: July 28, 2020
Accession Number: 0000950142-20-001849

View Document ↗ View on SEC.gov ↗